GALECTIN THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
GALECTIN THERAPEUTICS INC. (GALT) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 576.73 thousand shares for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-18.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2015-03-18
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2014-12-31 was 0.00 shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2014-09-30 was 0.00 shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2014-06-30 was 47.08K shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2014-03-31 was 529.65K shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2014 was 576.73K shares, a 1053.47% increase from fiscal 2013.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2013 was 50.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-18 | 47.08K shares derived: sum of 3 quarters · filed 2015-03-18 | 576.73K shares 10-K · filed 2015-03-18 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 47.08K shares derived: sum of 2 quarters · filed 2014-11-10 | 576.73K shares 10-Q · filed 2014-11-10 | |
| 2014-06-30 | 47.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 576.73K shares 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | 529.65K shares 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | 50.00K shares 10-K · filed 2015-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |